---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-21-007366"
form_type: "8-K"
ticker: "ANIK"
cik: "0000898437"
company_name: "Anika Therapeutics, Inc."
filed_at: "2021-11-01T23:59:59+00:00"
generated_at: "2026-06-28T16:00:48.627346+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Anika Therapeutics appoints Sheryl Conley to Board of Directors; adds orthopedic industry expertise

## Summary
- Appointed Sheryl Conley as independent director effective Oct 28, 2021; board expands from seven to eight members.
- Ms. Conley brings over 35 years of orthopedic experience, including 25 years at Zimmer as Group President and CMO.
- She will serve on the Audit Committee and received 8,179 restricted stock units vesting over three years.
- Currently President of AcceLINX and board member at Neuronetics (STIM) and Surgalign (SRGA).

## SEC filing metadata
- accession: 0001171843-21-007366
- form_type: 8-K
- ticker: ANIK
- cik: 0000898437
- company_name: Anika Therapeutics, Inc.
- filed_at: 2021-11-01T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/898437/000117184321007366/0001171843-21-007366-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/898437/000117184321007366/f8k_110121.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-21-007366
- JSON: https://secwatch.observer/filing/0001171843-21-007366.json
- Plain text: https://secwatch.observer/filing/0001171843-21-007366.txt

## Key facts
- Executive change
  Sheryl L. Conley was elected as Director at Anika Therapeutics, Inc..
  - Action: elected
  - Role: Director
  source text: elected Sheryl L. Conley as a member of the Board effective as of October 28, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/898437/000117184321007366/0001171843-21-007366-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.